Alzamend Neuro, Inc. (ALZN) stock
ALZNNasdaqPharmaceutical PreparationsFiscal year ends April 30
$1.04−0.09 (-7.96%)
Close on Nov 18, 2026Market cap $5.02MP/E –Yield –
Alzamend Neuro price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Alzamend Neuro's price to book ratio was 1.1× on Nov 11, 2026, against 1.3× a year earlier. Over the last 3 years it ranged from 0.4× to 292.8×, with a median of 6.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.1× | −0.5 |
| 2025 | Dec 31, 2025 | 1.6× | −6.8 |
| 2023 | Aug 31, 2023 | 8.3× | +2.2 |
| 2022 | Dec 30, 2022 | 6.1× | −6.0 |
| 2021 | Nov 30, 2021 | 12.1× | – |
See a number that looks wrong?